NewsRx

Search our medical news database

Cancer Therapy

New study on CT-guided PLC can be effective for lung cancer

Published in Cancer Weekly, December 30th, 2003

Endocare, Inc., a medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation, announced that new clinical data presented at the 89th scientific assembly and annual meeting of the Radiological Society of North America in Chicago, Illinois, shows that CT-guided, percutaneous lung cryotherapy (PLC) can be very effective in treating lung cancer tumors and results in minimal patient discomfort and minimal damage to adjacent tissues.

The study, presented by Dr. Peter Littrup, professor of radiology at Wayne State School of Medicine, is a summary of the results of PLC performed on 187 patients with 234 total lesions; 217...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook